Abstract:Objective To explore the association between multidrug resistance 1gene (MDR1)polymorphisms with the therapeutic efficacy of paliperidone (9-hydroxyrisperidone) and risperidone in Han Chinese schizophrenic patients. Methods One hundred and thirty-three schizophrenic patients were given paliperidone or risperidone LAI for a 12-week treatment. The PANSS was used to assess the main therapeutic efficacy, and the Clinical Global Impression-Severity (CGI-S) scale and the Personal and Social Function scale (PSP) were used to as the secondary therapeutic efficacy assessments. The patients were evaluated every 2 weeks. The polymerase chain reaction-based-restriction fragment length polymorphisms (PCRRFLP) and DNA sequencing were used to detect the genotypes of 5 candidate single nucleotide polymorphisms (SNPs). The association between MDR1 genotypes with the therapeutic efficacy was analyzed using the chi-square and ANOVA tests. Results There were no statistical significant differences between MDR1 gene polymorphism and the PANSS reduction rate or clinical efficacy rate(P ＞0.05). Non-parameter tests revealed that, patients carrying CC genotype of locus rs1045642 had better efficacy in negative symptom item ' difficulty in abstract thinking' ( Z = - 2. 62, P = 0. 009 ) and positive symptom item ' grandiosity '(Z = -2. 84,P =0. 005), and GG genotype of locus rs2032582 carriers had worse improvements in general psychopathology item 'tension' (Z = -2.50,P =0. 012), and as to patient who carried A allele of locus rs1202169 had better improvements in general psychopathology item 'active societal avoidance'(Z = -2. 09,P =0. 036), and CC genotype of locus rs13233308 carriers had worse improvements in items ' guilt feelings' (Z = - 2. 09, P = 0. 036) and ' lack of spontaneity and flow of conversation' (Z = - 2.73,P = 0. 006) ,TT genotype carriers had a better improvement in item ' tension' ( Z = - 2. 54, P = 0. 011).Secondary clinical efficacy analysis showed that locus C allele of rs1045642 might be associated with patients' higher PSP score (Z = -2. 18, P = 0. 029). Conclusion MDR1 gene polymorphisms may be not associated with the therapeutic efficacy of paliperidone and risperidone in Han Chinese schizophrenic patients, but may influence the clinical improvements of 'delusion' or 'active societal avoidance' of schizophrenia, which maybe provide references for schizophrenic patients' individual drug therapy.

Association Study of Multidrug Resistance 1 Gene Polymorphisms with Efficacy and Adverse Drug Reaction of Paroxetine in Major Depressive Patients

Association Of Brain-Derived Neurotrophic Factor Genetic Val66met Polymorphism With Severity Of Depression, Efficacy Of Fluoxetine And Its Side Effects In Chinese Major Depressive Patients

Study on the relationship between serotonin receptor 2A gene polymorphism and clinical response to paroxetine

The Relationship Between Single Nucleotide Polymorphisms in 5-HT2A Signal Transduction-Related Genes and the Response Efficacy to Selective Serotonin Reuptake Inhibitor Treatments in Chinese Patients with Major Depressive Disorder

Association of APC and REEP5 Gene Polymorphisms with Major Depression Disorder and Treatment Response to Antidepressants in a Han Chinese Population

Influence of methylenetetrahydrofolate reductase gene polymorphisms on antidepressant response]

5-Htr1a And 5-Htr2a Genetic Polymorphisms And Ssri Antidepressant Response In Depressive Chinese Patients

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated with Antidepressant Efficacy in Major Depressive Disorder

Influence of genetic polymorphisms in homocysteine and lipid metabolism systems on antidepressant drug response

[Association of CHRNA4 Gene Polymorphisms with Response to Antidepressant among Ethnic Han Chinese].

Catecholamine Pathway Polymorphisms and Antidepressant Response.

[Association of TPH2 Gene Polymorphism with Response to Antidepressant Treatment among Ethnic Han Chinese Population].

TPH, SLC6A2, SLC6A3, DRD2 and DRD4 Polymorphisms and Neuroendocrine Factors Predict SSRIs Treatment Outcome in the Chinese Population with Major Depression.

Serotonin transporter gene and antidepressant efficacy of selective serotonin reuptake inhibitors in adolescent depression

ABCB6, ABCB1 and ABCG1 Genetic Polymorphisms and Antidepressant Response of SSRIs in Chinese Depressive Patients.

Association Between 5-HTR1A Gene C-1019G Polymorphism and Antidepressant Response in Patients with Major Depressive Disorder: A Meta-Analysis

Neither cytochrome P450 family genes nor neuroendocrine factors could independently predict the SSRIs treatment in the Chinese Han population.

Association of multidrug resistance 1 gene polymorphism with the clinical efficacy of paliperidone and risperidone in schizophrenic patients

Association analysis of COMT/MTHFR polymorphisms and major depressive disorder in Chinese Han population.

Association of tryptophan hydroxylase 2 gene polymorphisms with major depression disorder and antidepressant treatment response